Alnylam Pharmaceuticals, Inc.
Multi-targeted single entity conjugates
Last updated:
Abstract:
The present invention relates, in general to, compounds, compositions and methods useful for modulating gene expression of multiple target nucleic acids by a single chemical entity.
Status:
Grant
Type:
Utility
Filling date:
15 Jul 2016
Issue date:
6 Jul 2021